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Summary
Dysregulation of splicing factor expression and altered alterna-
tive splicing are associated with aging in humans and other
species, and also with replicative senescence in cultured cells.
Here, we assess whether expression changes of key splicing
regulator genes and consequent effects on alternative splicing
are also associated with strain longevity in old and young mice,
across 6 different mouse strains with varying lifespan (A/J,
NOD.B10Sn-H2b/J, PWD.Phj, 129S1/SvlmJ, C57BL/6J and WSB/EiJ).
Splicing factor expression and changes to alternative splicing
were associated with strain lifespan in spleen and to a lesser
extent in muscle. These changes mainly involved hnRNP splicing
inhibitor transcripts with most changes more marked in spleens
of young animals from long-lived strains. Changes in spleen
isoform expression were suggestive of reduced cellular senes-
cence and retained cellular proliferative capacity in long-lived
strains. Changes in muscle isoform expression were consistent
with reduced pro-inflammatory signalling in longer-lived strains.
Two splicing regulators, HNRNPA1 and HNRNPA2B1, were also
associated with parental longevity in humans, in the InCHIANTI
aging study. Splicing factors may represent a driver, mediator or
early marker of lifespan in mouse, as expression differences were
present in the young animals of long-lived strains. Changes to
alternative splicing patterns of key senescence genes in spleen
and key remodelling genes in muscle suggest that correct
regulation of alternative splicing may enhance lifespan in mice.
Expression of some splicing factors in humans was also
associated with parental longevity, suggesting that splicing
regulation may also influence lifespan in humans.
Key words: isoforms; lifespan; longevity; mouse; mRNA
splicing; splicing factors.
Introduction
Aging is a dynamic, multisystem process, which is highly heterogeneous
in humans with some people surviving disease-free until advanced age
whilst others succumb to age-related conditions in mid-life. The factors
underlying individual lifespan are currently unclear, but increasing our
understanding of determinants of longevity and ‘healthspan’ are key
aims for the future.
Correct expression and regulation of genes is critical for maintenance
of cellular and organismal function. Alternative splicing, the process by
which single genes can make multiple gene products in an adaptive and
reactive fashion is a key part of this process (Cartegni et al., 2002).
Indeed, breakdown in the regulation of mRNA splicing is a prominent
feature in many age-related diseases such as Alzheimer’s disease,
Parkinson’s disease and several tumour types (Scuderi et al., 2014;
Danan-Gotthold et al., 2015; Lisowiec et al., 2015; Lu et al., 2015). This
may indicate that defects in the splicing machinery may cause the
cellular response to stress to be less specific, with effects on cellular
resiliency and accumulation of DNA damage. We have previously
identified deregulation of splicing factor expression and alternative
splicing as a key factor in normal human and cellular aging (Harries
et al., 2011; Holly et al., 2013). Alternatively expressed isoforms also
demonstrate tissue-specific differences in aging, as they do for many
other phenomena (Holly et al., 2013). Splicing factors themselves
demonstrate high species conservation (Barbosa-Morais et al., 2006),
whereas patterns of alternative splicing are partially determined by
genetic differences and may be species specific. Splicing patterns show
drastically more interspecies variability than gene expression with only
50% of alternatively expressed isoforms being conserved between
species (Barbosa-Morais et al., 2012). Alternatively regulated splice sites
demonstrating temporal, spatial or reactive expression are less likely to
show species conservation (Garg & Green, 2007).
Several splicing factors have been suggested to be involved in
organismal lifespan. The pre-mRNA processing factor 19 homologue
(SNEV) protein, important for spliceosome assembly and mRNA process-
ing, has been shown to suppress cellular senescence and suppress
apoptosis when phosphorylated by the ataxia-telangiectasia (ATM)
kinase in endothelial cells (Dellago et al., 2012). The DNA damage
protein ATM also appears to be an important regulator of splicing factor
expression in our previous work, since targeted gene knockdown of the
ATM gene resulted in increased levels of splicing factor expression in
fibroblasts (Holly et al., 2013). There is also evidence from systemic
models. A network-based model of genes altered by calorific restriction
across 17 tissues in mice revealed that the largest and most responsive
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gene regulatory module was associated with mRNA processing, with a
disproportionally large number of genes being involved in splicing,
metabolism, processing and biosynthesis of mRNA (Swindell, 2009).
Finally, a study of the relationship between copy number variation (CNV)
and longevity in humans revealed that lifespan-associated CNVs were
preferentially located in or near genes encoding proteins involved in
splicing control. This led them to conclude that genetic variation that
disrupts the processes of alternative splicing may have long-term effects
on lifespan (Glessner et al., 2013).
The study of inbred strains of mice has proven fruitful in uncovering
factors associated with lifespan, as for other phenotypes. The Jackson
Laboratory has characterized 30 strains of mice, for aging and longevity-
related traits (Yuan et al., 2009, 2011). Initial work with this resource
identified that plasma IGF1 levels were related to lifespan in rodents
(Yuan et al., 2009). This collection, together with the associated
repository of mouse phenome data, represents a rich resource (Bogue
et al., 2014). Here, we have harnessed this resource to assess the
contribution of regulation of alternative splicing to longevity in mice.
We have systematically assessed the expression of splicing factors
previously demonstrated to be altered in human aging in relation to
lifespan in six mouse strains of different longevities. Our study design is
illustrated in Fig. 1. Splicing factor expression and alternative splicing of
key genes are associated with lifespan in mouse spleen tissue and to a
lesser extent in mouse muscle, suggesting that aging effects may be
driven by immune tissues. Some strain differences in expression are most
marked in the young mice, suggesting that they may represent
determinants or early markers of longevity rather than representing
secondary effects of aging. We also identified differences in expression
levels of alternatively expressed isoforms of key aging genes indicative of
reduced cellular senescence, maintained cellular proliferative capacity
(spleen) and reduced pro-inflammatory signalling (muscle) in long-lived
mouse strains. Two splicing factors, HNRNPA2B1 and HNRNPA1, were
also associated with parental longevity in a large population study of
aging, suggesting that regulation of splicing may also be involved in
lifespan in human populations.
Results
Splicing factor transcript expression is associated with
lifespan in mouse spleen and to a lesser extent in muscle
tissues
We assessed splicing factors that we have previously demonstrated to be
altered in human aging in relation to lifespan in 6 mouse strains of
different longevities and in samples from both old and young mice as in
Fig. 1. The expression of 8/15 and 3/15 splicing factors was associated
with strain lifespan in mouse spleen and muscle tissue, respectively.
In spleen, we found associations between strain lifespan and the
expression of the Hnrnpa1, Hnrnpa2b1, Hnrnpk, Hnrnpm, Hnrnpul2,
Sf3b1, Srsf3 and Tra2b genes (beta coefficients 0.40, 0.26, 0.32,
0.31, 0.22, 0.13 and 0.36; P = 0.01, 0.02, 0.003, 0.003, 0.04,
0.05, 0.02 and 0.02, respectively; Fig. 2A, Table S1). When an analysis
was carried out to assess interactions between strain lifespan and mouse
age, we found effects in both young and old mice of long-lived strains
for all associated genes except Hnrnpul2. In the case of Hnrnpa1 and
Hnrnpa2b1 genes, these differences were more marked in the young
mice of long-lived strains (beta coefficients 0.14 and 0.19, P = 0.001
and < 0.0001 in the young long-lived mice compared with 0.09 and
0.12; P = 0.01 and 0.02 for the old long-lived mice for Hnrnpa1 and
Hnrnpa2b1, respectively; Table S9). For Srsf3, the associations between
splicing factor expression/age and splicing factor expression/strain
median lifespan appear to be comparable, whereas for Tra2b, our data
suggest that the effects of age are stronger than those of lifespan
(Table S9). The majority (5/8) of the splicing factors demonstrating
association of expression differences with lifespan belonged to the
hnRNP class of splicing inhibitors, with only 2 splicing activators (Srsf3
and Tra2b) showing expression changes with lifespan. The remaining
associated splicing factor, Sf3b1, encodes a component of the U2 snRNP
in the core spliceosome complex, rather than a splicing regulator. When
data were assessed by binary logistic regression to allow for nonlinearity
of response, all but one (Hnrnpul2) of the splicing regulators associated
with lifespan in spleen remained associated with median strain lifespan
(Table S10).
Fewer splicing factors were associated with strain lifespan in muscle
tissue (Fig. 2B, Table S2). Hnrnpa0 expression was found to be positively
correlated with long life (beta coefficient 0.36; P = 0.01), whereas
Hnrnpd and Srsf3 transcripts both demonstrated reduced expression
(beta coefficients 0.24 and 0.40; P = 0.03 and 0.02, respectively).
Interaction analysis revealed that the Srsf3 effect was again driven by
effects in the young animals of the long-lived strains (beta coefficient
0.14, P = 0.01 in the young long-lived mice compared with beta
coefficient 0.05, P = 0.28 in the old long-lived mice; Table S9). Again
2/3 lifespan-associated splicing factors represented hnRNP splicing
inhibitors rather than SRSF splicing activators. When data were assessed
by binary logistic regression to allow for nonlinearity of response, all of
the splicing regulators associated with lifespan in muscle remained
associated with median strain lifespan (Table S11). Effects were tissue
Fig. 1 Schematic of study design. This figure shows the experimental strategy
employed to assess the effects of strain longevity and mouse age on the expression
of an a priori panel of splicing factors (SFs).
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specific, with little overlap between lifespan-associated splicing factors in
spleen and those in muscle, with only Srsf3 common to both data sets.
Alternatively spliced genes demonstrate longevity-associated
isoform changes in mouse spleen and muscle tissue
In spleen, we found splicing differences in association with lifespan for 4/
8 genes tested (Fig. 3A; Table S3). Both uc008toi.1 and uc008toh.1
transcripts encoding p16INK4A and p14ARF isoforms of the Cdkn2a
gene were expressed at lower levels in the long-lived strains (beta
coefficients 0.43 and 0.59; P = 0.002 and < 0.0001 for uc008toi.1
[p16INK4A] and uc008toh.1 [p14ARF], respectively). Analysis of the
interaction of strain longevity and mouse age revealed that although the
effects on Cdkn2a isoform expression increased with age as expected in
both average-lived and long-lived mice, the increase in expression was
much less marked in the old long-lived mice than in old mice of average
lifespan (beta coefficients 0.44 and 0.50, P = <0.0001 and < 0.0001 for
the old average-lived mice compared with beta coefficients 0.22 and
0.27, P = 0.01 and 0.001 for the old long-lived mice; Table S9).
We also found expression of the uc007bju.2 isoform only of the Fn1
gene to be increased in the long-lived strains (beta coefficient 0.25,
P = 0.02). There is increased expression of the long isoform of the Trp53
gene encoding full-length p53 (uc007jql.2/uc007jqn.2), but reduced
expression of the truncated p53AS isoforms (uc011xww.1/uc007jqm.2;
beta coefficients 0.41 and 0.35, P = 0.009 and 0.03 for full-length
Trp53 and truncated p53AS isoforms, respectively). Assessment of the
interaction between strain longevity and mouse age revealed that
expression of the full-length p53 isoform is only significantly increased in
the young animals of long-lived strains (in comparison with young
animals of short-lived strains P = 0.004; the older animals were not
significantly different to young short-lived strains P > 0.05) and that
diminished expression of p53AS was only significantly decreased in the
Fig. 2 Splicing factor expression according to mouse lifespan. This plot illustrates
association between median lifespan and slicing factor expression in total RNA
from spleen (A) or muscle (B) tissues in mice of 6 strains of different longevities, as
assessed by linear regression against median strain lifespan. The identity of specific
splicing factors is given on the x-axis. The log10 P-values for associations between
lifespan and splicing factor expression from mice of strains with different lifespans
and of different ages are given on the y-axis. Direction of effect is also indicated;
data appearing above the zero line on the y-axis represent positive associations,
whilst data appearing below the zero line represent negative associations. Analysis
including all animals in the sample is given by dark grey bars, in young animals only
by medium grey bars and in old animals only by light grey bars. The dotted line
refers to a P-value cut-off for statistical significance of P = 0.05.
Fig. 3 The expression of alternative isoforms of key genes according to mouse
lifespan. This plot illustrates association between median lifespan and the
expression of alternatively expressed isoforms of key genes in total RNA from
spleen (A) or muscle (B) tissues in mice of 6 strains of different longevities as
assessed by linear regression against median strain lifespan. The identity of specific
splicing factors is given on the x-axis. The log10 P-values for associations between
lifespan and splicing factor expression from mice of strains with different lifespans
and of different ages are given on the y-axis. Direction of effect is also indicated;
data appearing above the zero line on the y-axis represent positive associations,
whilst data appearing below the zero line represent negative associations. Analysis
including all animals in the sample is given by dark grey bars, in young animals only
by medium grey bars and in old animals only by light grey bars. The dotted line
refers to a P-value cut-off for statistical significance of P = 0.05.
Splicing factor expression and longevity, B. P. Lee et al. 905
ª 2016 The Authors. Aging Cell published by the Anatomical Society and John Wiley & Sons Ltd.
old animals of long-lived strains (P = 0.009, in comparison with young
animals of short-lived strains; other groups were P > 0.05, Table S9).
Finally, expression of the full-length uc007rjg.1 isoform of the Vcan gene
is upregulated (beta coefficient 0.34, P = 0.001).
In mouse muscle, expression of isoforms of all five genes tested in
relation to lifespan was altered (Fig. 3B, Table S4). First, expression of the
full-length uc008mht.1 isoform of the Il1b gene was reduced in the
long-lived strains (beta coefficient 0.46, P = 0.007), whilst the intron-
retained uc008mhu.1 Il1b isoform was unaffected. Interaction analysis
revealed that this difference was limited to the young mice of the long-
lived strains (P = 0.004 for young long-lived mice compared with
P = 0.34 for the old long-lived mice). Expression levels of the intron-
retained uc008wuv.1 and full-length uc008wuw.1 isoforms of the Il6
gene were also reduced (beta coefficient 0.48, P = 0.006 and 0.28,
P = 0.01, respectively). Interaction analyses revealed that the effects on
the intron-retained isoform were significant in the young long-lived mice
only (P = 0.04 for young long-lived mice compared with P = 0.72 for old
long-lived mice; Table S9).
Expression of the uc012cyg.1/uc008rlx.1 isoforms which encode the
long full-length forms of the Nfkb1 gene was greater in long-lived strains
(beta coefficient 0.31, P = 0.005). No difference was seen in the
expression of the noncoding truncated uc012cyf.1 Nfkb1 isoform.
Isoform usage for the Stat1 gene in long-lived strains differed; the
uc007axz.1 and uc007aya.2 isoforms of Stat1 that both encode ‘variant
2’ of the STAT1 protein demonstrated diminished expression in the long-
lived strains (beta coefficients 0.63, P = <0.0001), whereas the Stat1
uc007ayc.2 isoform encoding ‘variant 1’ demonstrated increased
expression in the long-lived strains (beta coefficient 0.46, P = 0.007).
Interaction analysis revealed that the decrease in Stat1 variant 2
expression was present only in the old long-lived mice (P = 0.01 in old
long-lived mice compared with P = 0.28 in the young long-lived mice;
Table S9). The greater Stat1 variant 1 expression was driven by effects in
the young long-lived mice (P = 0.03 in young long-lived mice compared
with P = 0.95 in old long-lived mice). Transcript uc007ayb.2, encoding
Stat1 ‘variant 3’, was also upregulated (beta coefficient 0.33, P = 0.005)
although this was seen in both young and old animals of long-lived
strains. Finally, expression of both the uc012arb.2 and uc008cgs.2
isoforms of the Tnf gene which encode TNF variants 1 and 2 were
reduced in muscle (beta coefficients 0.27 and 0.18, P = 0.02 and
0.04 for uc012arb.2 and uc008cgs.2, respectively). Interaction analyses
revealed that the effect for Tnf variant 1 is most marked in the old long-
lived animals (P = 0.008 in the old long-lived animals compared with
P = 0.05 in the young long-lived animals, Table S9).
Few splicing factors are associated with age in mouse spleen
and muscle tissues
Associations between mouse age and splicing factor expression were
less marked than those seen for strain longevity (Fig. 4A,B, Tables S5 and
S6). In spleen, we found reduced expression of the Hnrnpa2b1, Srsf1,
Srsf3 and Tra2b transcripts in old mice (beta coefficients 0.46, 0.34,
0.45 and 0.53; P = 0.005, 0.05, 0.007 and 0.008, respectively).
Effects on Srsf1, Srsf3 and Tra2b expression were evident in old animals
of both average-lived and long-lived strains, but interaction analysis
revealed that the age-associated difference in Hnrnpa2b1 expression
was most marked in the old animals of strains of average lifespan (beta
coefficients 0.11, P = 0.02 in the old long-lived animals compared to
beta coefficient 0.13 P = <0.0001 in the old average-lived animals).
Age-associated changes to splicing factor expression were much less
evident in muscle tissue, with only Hnrnpa1 demonstrating increased
expression (beta coefficient 0.22, P = 0.05). Analysis of cluster patterns
for age revealed considerable inter- and intrastrain heterogeneity in
splicing factor expression (Fig. S1).
Alternatively expressed isoforms demonstrate differential
expression with age in mouse spleen and muscle tissue
Despite the small numbers of splicing factors demonstrating age-
associated differences in splicing factor expression, we noted differences
in alternative splicing in both spleen and muscle from aged mice
(Fig. 5A,B, Tables S7 and S8).
In mouse spleen, we identified increased expression of both uc008-
toi.1 and uc008toh.1 transcripts encoding p16INK4A and p14ARF
isoforms of the Cdkn2a gene in the old animals as expected (beta
coefficients 0.40 and 0.53, P = <0.0001 and 0 < 0.0001, respectively).
Interaction analyses revealed the age-associated increase in both Cdkn2a
Fig. 4 Splicing factor expression according to mouse age. This plot illustrates
association between age and splicing factor expression in total RNA from spleen
(A) or muscle (B) tissues in young (6 months) vs. old (20–22 months) mice. The
identity of specific splicing factors is given on the x-axis. The log10 P-values for
associations between age and splicing factor expression from mice of different
ages and of different strains are given on the y-axis. Direction of effect is also
indicated; data appearing above the zero line on the y-axis represent positive
associations, whilst data appearing below the zero line represent negative
associations. Analysis including all animals in the sample is given by dark grey bars,
in animals of average-lived strains only by medium grey bars and in long-lived
animals only by light grey bars. The dotted line refers to a P-value cut-off for
statistical significance of P = 0.05.
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isoforms to be significantly reduced in old animals of long-lived strains as
described above. We also identified decreased expression of both
uc008yrw.1 (full length) and uc008yrx.1 (exon skipped) isoforms of the
Chek2 gene with increasing age (beta coefficients 0.33 and 0.35,
P = 0.02 and 0.01, respectively). Interaction analyses between mouse
age and strain longevity revealed that reduced expression of the full-
length Chek2 isoform was more marked in the old animals of the long-
lived strains (beta coefficient 0.26, P = <0.0001 in the old long-lived
animals compared with beta coefficient 0.24, P = 0.003 in the old
average-lived animals; Table S9). Trp53 isoforms also demonstrated
effects with age in mouse spleen. With age, there was a reduction in
levels of transcripts encoding both full-length p53 (uc007jql.2/
uc007jqn.2) and also those encoding the truncated alternatively spliced
p53AS (uc007jqm.2) isoform (beta coefficients 0.24 and 0.24,
P = 0.02 and 0.03, respectively).
In mouse muscle, we found increased expression of both the full-
length (uc008mht.1) and the intron-inclusion (uc008mhu.1) Il1b tran-
scripts with age (beta coefficients 0.37 and 0.39, P = 0.001 and
< 0.0001). The old animals also demonstrated elevated expression of the
uc008wuv.1 isoform of the Il6 gene, which contains a retention of intron
4 relative to the consensus transcript (beta coefficient 0.44, P = 0.003).
Old animals also demonstrated reduction of uc007ayd.2, uc007aya.2,
uc007ayb.2 and uc007ayc.2 isoforms of the Stat1 gene, with the effects
on uc007aya.2 being revealed by interaction analysis between mouse
age and strain lifespan to be present exclusively in the old animals of
long-lived strains (beta coefficient 0.17, P = 0.01; Table S9).
The expression of some splicing factors is associated with
parental longevity in a large human population
We examined the expression of 15 splicing factors identified through the
mouse work described in this study and previous analyses (Holly et al.,
2013) and determined that 2 genes, HNRNPA2B1 and HNRNPA1,
demonstrated associations of their expression with parental longevity, as
defined in Dutta et al. (2013a) in the human InCHIANTI population study
as well as in mice (Table 1). HNRNPA2B1 transcripts demonstrated
increased expression in the offspring of long-lived parents (beta
coefficients 0.12, P = 0.017), whereas HNRNPA1 demonstrated reduced
expression in the offspring of long-lived parents (beta coefficient 0.09;
P = 0.035, respectively; Table 1). Hnrnpa1 demonstrates reduced
expression in association with longevity in both man and mouse,
whereas Hnrnpa2b1 shows elevated expression with longevity in people,
but reduced expression with longevity in mice.
Genetic variation within Hnrnpa2b1 and Hnrnpa1 that is
discrepant between strains is unlikely to contribute to
differences in gene expression
We have carried out a bioinformatic analysis of the potential for genetic
variation that is discrepant between strains of mice to affect the
regulation of the Hnrnpa2b1 and Hnrnpa1 genes. These genes were
selected because their expression is associated with longevity in both
mouse and man. The Hnrnpa2b1 gene harbours 14 genetic variants that
are discordant between strains. Two of these variants, rs51031918 and
rs252413833, are associated with changes to the binding efficiencies of
SRSF2 and SRSF5 splicing enhancers (see Table S12). These changes are,
however, very subtle and may not adversely affect SRSF2 or SRSF5
binding. Similarly, two Hnrnpa1 variants (rs32398879 and rs50030666)
are discordant between the strains. One of these, rs50030666, lies in a
cassette exon which is intronic in some Hnrnpa1 isoforms, but coding in
others (see Table S12). The coding change causes the substitution of
glycine residue for a similarly sized serine residue with equivalent charge.
No other predicted effects of genetic variation on transcription factor
binding, RNA regulatory elements (A-rich elements, C to U RNA editing
sites or microRNA binding sites) were identified for any variant studied.
Discussion
Splicing factor expression has been shown to be conclusively associated
with chronological age in humans (Harries et al., 2011) and also with
cellular senescence in multiple human primary cell lines in culture (Holly
et al., 2013), indicating that these factors may be linked with cellular
plasticity and adaptability during the aging process. Here, we have
assessed the potential relationships between splicing factor expression
and alternative splicing with strain longevity across 6 mouse strains of
variable medium to long lifespans, in both young and old animals. We
also assessed associations between splicing factor expression and
parental longevity in the offspring of long-lived parents in humans.
Fig. 5 The expression of alternative isoforms of key genes according to mouse
age. This plot illustrates association between the expression of age and the
expression of alternatively expressed isoforms of key genes in total RNA from
spleen (A) or muscle (B) tissues in young (6 months) vs. old (20–22 months) mice.
The identity of isoforms is given on the x-axis. The log10 P-values for associations
between age and the expression of alternative isoforms from mice of different
ages and of different strains are given on the y-axis. Direction of effect is also
indicated; data appearing above the zero line on the y-axis represent positive
associations, whilst data appearing below the zero line represent negative
associations. Analysis including all animals in the sample is given by dark grey bars,
in animals of average-lived strains only by medium grey bars and in long-lived
animals only by light grey bars. The dotted line refers to a P-value cut-off for
statistical significance of P = 0.05.
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We have found that over half of the splicing factors tested are associated
with longevity in mouse spleen, and to a lesser extent in mouse muscle
and that these changes are accompanied by alterations to the profile of
selected alternatively expressed isoforms in both tissues. Two splicing
factors, HNRNPA1 and HNRNPA2B1, also showed evidence of an
association with parental longevity in humans. These results, to our
knowledge, represent the first link between the regulation of alternative
splicing and inherited longevity traits in mammals.
In spleen, 7/8 splicing factors tested demonstrated associations with
strain longevity in both young and old animals, with effects being
predominant in the young animals of longer-lived strains suggesting that
these differences in splicing factor expression are not the end result of
aging processes as such, but rather may represent fundamental
differences in factor expression that drive or contribute to the aging
process. It is possible that changes happening early on in life may set the
scene for future longevity, which is an interesting concept given that
several genes such as Foxo1, known to be associated with extended
lifespan, are developmental genes (Lunetta et al., 2007). It is very
difficult to predict what the consequence of these changes will be to the
overall level or pattern of splicing in long-lived mice or humans, since
splice site choice at any given exon: intron junction is determined by the
balance of activators and repressors, and that this balance is individually
determined for each splice site in each gene (Cartegni et al., 2002).
However, diminished splicing factor expression may be beneficial in
younger animals, since both SRSF and hnRNP splicing factors are known
to have oncogenic features (Gautrey et al., 2015; Goncalves & Jordan,
2015; Guo et al., 2015). Lower splicing factor expression in younger
animals may thus protect against an earlier death from malignancy.
We also found clear evidence to suggest tissue specificity of effect
which is very common in studies of splicing with 8/15 (53%) splicing
factors showing associations with strain longevity in spleen, but only 3/
15 (20%) in muscle. It would be interesting to determine whether the
splicing events targeted by these sets of splicing factors also show
associations between median strain lifespan and splice site usage, but
such analysis would be very difficult due to degeneracy of splicing factor
binding sites, potential for compensation by other splicing factors and
the fact that splice site usage is dependent on the balance of enhancers
and silencers rather than on the binding of a specific splicing factor per
se. The pattern of longevity-associated splicing regulator transcripts
showed little overlap between the spleen and muscle data sets, with only
changes to Srsf3 expression being common to both tissues. This is in line
with our previous findings, as we have previously shown that although
fibroblasts and endothelial cells that have undergone in vitro senescence
both show deregulation of splicing factors, the patterns of precisely
which regulators are altered show quite marked differences between cell
types (Holly et al., 2013). Spleen is a lymphoid organ, consisting of large
numbers of white blood cells. Most of the transcripts extracted from
spleen will arise from B cells, T cells and mononuclear phagocytes. Our
findings may thus reflect the hypothesis that aging of the immune
system is one of the drivers of development of aging phenotypes
(Franceschi & Campisi, 2014). It should also be considered that the
preponderance of splicing factor expression changes in spleen compared
with muscle could also reflect an accelerated rate of aging and more
extensive tissue modification in spleen compared to muscle. White blood
cells are also highly heterogeneous, reactive and proliferative but
relatively unspecialized compared to the highly differentiated nonpro-
liferative muscle cells. It may be that muscle requires less adaptive
response than spleen cells, since it has a defined and tightly regulated
function with less need to respond to environmental challenge.
Previous work from our group has identified that offspring of long-
lived parents may have better health (Dutta et al., 2013a,b). In the
current study, two of the associations between splicing factor expression
and longevity were also seen in RNA samples derived from the peripheral
blood of participants in the InCHIANTI study (Ferrucci et al., 2000),
where we found relationships between expression of the HNRNPA2B1
and HNRNPA1 transcripts and parental longevity. HNRNPA2B1 demon-
strated increased expression in blood RNA from people with at least one
long-lived parent, whereas parental longevity (as a continuous trait
reflecting the combined age at death of both parents) was associated
with lower HNRNPA1 expression (Table 1). Hnrnpa1 is also downregu-
lated with greater lifespan in mouse splenocytes, but the HNRNPA2B1
effect in humans is reversed compared to what we observe in the mice.
This may be because the association between Hnrnpa2b1 expression and
longevity is most marked in the young animals of the long-lived strains,
and our human subjects are mostly elderly, with a mean age of
approximately 75 years (Harries et al., 2011). Interestingly, both Hnrn-
pa2b1 and Hnrnpa1 are known to be determinants of lifespan in
Drosophila species, by virtue of their regulation of the TDB-43 protein
(Romano et al., 2014). TDB-43 is crucial in fruit flies for correct splicing
and regulation of mRNA stability and is associated with amyotrophic
lobar sclerosis and frontotemporal lobar degeneration in humans
(Neumann et al., 2007; Kim et al., 2013). Mutations have also been
described in age-related diseases such as Alzheimer’s, Parkinson’s and
Huntington’s diseases (Baloh, 2011). Recent studies have shown that the
action of TDB-43 relies on its ability to tether hnRNPA2B1 and hnRNPA1
Table 1 Associations between splicing factor expression and parental longevity in
humans (the InCHIANTI population)
Gene name Probe Id Beta coefficient
95% Confidence
intervals P-value
HNRNPA2B1 ILMN_1886493 0.116 0.020 0.212 0.017
HNRNPA1 ILMN_1676091 0.091 0.176 0.006 0.035
HNRNPA2B1 ILMN_2369682 0.088 0.002 0.175 0.044
TRA2B ILMN_1742798 0.092 0.001 0.186 0.051
HNRNPA1 ILMN_1661346 0.069 0.004 0.143 0.065
SRSF1 ILMN_1795341 0.082 0.008 0.171 0.073
HNRNPD ILMN_2321451 0.088 0.010 0.186 0.078
HNRNPK ILMN_1701753 0.066 0.176 0.043 0.232
HNRNPUL2 ILMN_2072091 0.076 0.053 0.205 0.246
HNRNPK ILMN_2378048 0.060 0.058 0.178 0.319
SRSF18 ILMN_2161357 0.068 0.072 0.209 0.341
HNRNPUL2 ILMN_1810327 0.055 0.066 0.176 0.374
HNRNPA1 ILMN_2220283 0.034 0.051 0.119 0.432
SRSF2 ILMN_1696407 0.047 0.074 0.167 0.446
HNRNPD ILMN_1751368 0.034 0.137 0.068 0.511
SRSF6 ILMN_1697469 0.033 0.077 0.143 0.552
SRSF6 ILMN_1754304 0.030 0.078 0.138 0.585
HNRNPA0 ILMN_1753279 0.035 0.164 0.095 0.598
HNRNPA1 ILMN_1663447 0.034 0.168 0.101 0.624
HNRNPA1 ILMN_1720745 0.025 0.080 0.131 0.637
HNRNPM ILMN_2385173 0.029 0.161 0.103 0.668
SRSF6 ILMN_1805371 0.026 0.149 0.096 0.673
SF3B1 ILMN_1712347 0.022 0.151 0.107 0.738
SF3B1 ILMN_1705151 0.017 0.091 0.125 0.754
HNRNPM ILMN_1745385 0.016 0.119 0.086 0.756
HNRNPA1 ILMN_2175075 0.012 0.126 0.102 0.838
SRSF3 ILMN_2389582 0.004 0.118 0.125 0.951
The relationship of parental longevity with expression of 15 unique splicing factors
in 405 individuals by multivariate linear regression. Genes demonstrating
significant associations at P = <0.05 are indicated in bold underlined text.
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proteins, and disruption or abolition of this association dramatically
reduces lifespan in Drosophila (Romano et al., 2014).
The consequences of altered splicing in spleen give a broad picture of
altered expression and processing of genes involved in reduced cell
senescence, superior DNA repair and retained cellular proliferative
capacity in the long-lived strains. Old animals of long-lived strains of mice
expressed reduced amounts of Cdkn2a isoforms compared with old
animals of average-lived strains. Cdkn2a is an important marker of
cellular senescence (Tominaga, 2015) and ablation of Cdkn2a expression
reverses aging phenotypes in klotho mice (Sato et al., 2015), indicating
that old animals of long-lived strains may have lower levels of senescent
cells. Young animals of longer-lived strains also expressed profiles of
Trp53 isoforms consistent with enhanced transcription and cell growth
properties compared to young animals of average-lived strains, since
they express higher levels of full-length p53 and lower levels of truncated
p53AS which is thought to have antagonistic function (Wu et al., 1997;
Almog et al., 2000; Huang et al., 2002). Altered splicing of inflamma-
tory genes involved in muscle remodelling produces a picture consistent
with lower levels of pro-inflammatory signalling by virtue of lower levels
of Il1b and Il6 expression in young animals and reduced Tnf signalling in
the older animals of long-lived strains.
We saw fewer associations of splicing factor expression with
chronological age than we expected based on our previous human
data. Our previous work suggests that splicing factor expression is
strongly associated with age in humans and with cellular senescence in
human cell models (Harries et al., 2011; Holly et al., 2013). In our
human work, the per-year age-related changes in splicing factor
expression were also relatively small (beta coefficients ranging from
0.01 to 0.005) (Holly et al., 2013), which may explain why strong
effects were not seen in the current mouse study where our sample
numbers were much smaller. There is also considerable interstrain
heterogeneity for most splicing factors; the young animals of one strain
may express lower basal levels of splicing factors than the older animals
of another and effects of aging may thus be difficult to detect in small
numbers of samples (Fig. S1). These data suggest that the associations of
splicing factor expression with longevity across strains may actually be
considerably larger than effects of age alone on splicing factor
expression within strains. Again, most changes seen in this study were
seen in spleen, which is consistent with a key role in senescence for
immune-mediated drivers of aging and aging phenotypes.
The limitations of our study include the relatively small sample sizes,
restriction of our analyses to a small number of tissues, and the fact that
we have assessed splicing patterns only at the mRNA level. Gene
expression is a highly variable parameter in biological systems, so future
experiments are likely to need larger sample sizes and assessment of
potential effects in other tissue types, as well as assessment of effects on
protein levels. Although the genes tested were selected a priori and
therefore do not require adjustment for multiple testing, one must
recognize that this does not entirely remove the possibility of false
positives. It must also be considered that differences in splicing factor
and isoform expression may arise not only from changes in the amount
of transcription, but also from differences in the relative stabilities of
different isoforms. These changes may form part of the mechanistic basis
for our associations, as we would not expect stability changes unrelated
to longevity to associate statistically with strain median lifespan. Finally,
in the human follow up work described here, we were also restricted by
the availability of expression data for all interesting splicing factors on
the array and the likelihood that any effects were likely to be moderate
on a per-year basis as they were in our previous human age data. This is
likely to have reduced our power in the human study, and thus further
work in larger populations is now required to definitively explore this
possibility in human subjects.
Another potential caveat is that the splicing factor expression
differences we have discovered in this study reflect other strain
differences that are unrelated to longevity. Whilst this is a possibility,
the links between splicing factor expression and aging in humans and
other animals are well documented from our previous work (Harries
et al., 2011; Holly et al., 2013) and that of other groups (Meshorer &
Soreq, 2002). Our observation that the lifespan-associated expression
changes relating to Hnnrpa2b1 and Hnrnpa1we observe in mice are also
translatable to humans is also supportive of our conclusions. More
broadly, the importance of splicing factors in determination of lifespan is
also suggested by studies of the effects of calorific restriction in mice
(Swindell, 2009) and studies of the relationship between copy number
variant (CNV) polymorphisms and longevity in humans (Glessner et al.,
2013).
Some of the genetic differences between strains may actually
contribute mechanistically to the differences in strain median lifespan.
To that effect, we carried out a bioinformatic analysis on the potential
for genetic variation discordant between strains to lead to gene
regulation differences for Hnrnpa2b1 and Hnrnpa1, where we also
found effects in man. We discovered some minor changes to the
bioinformatically predicted strength of SRSF2 and SRSF5 binding within
Hnrnpa2b1 and a potential amino acid change for an alternatively
expressed isoform of Hnrnpa1. Although these predictions are interest-
ing, the predicted effects of the changes on Hnrnpa2b1 or Hnrnpa1
expression or activity are likely to be slight. The splicing effects cause only
a slight alteration to predicted binding efficiency of SRSF2 or SRSF5, and
the coding change involves the substitution of a serine for a glycine in an
alternatively spliced cassette exon of Hnrnpa1, which may not comprise
the major isoform at this locus. These amino acids are in any case of
similar size and charge and may not cause much change to protein
functionality. It is likely the effects on median strain longevity arise from
multiple changes in many genes.
To be able to assign definitive causality for a role for splicing factors
as determinants of longevity, it would be necessary to carry out
detailed functional experiments in vivo and in vitro, which could form
the basis for future studies. Such studies could comprise constitutive or
conditional knockout or overexpression studies in animal models
followed by assessment of effects on lifespan, or in vitro manipulation
of splicing factor levels followed by investigation of effects on cellular
senescence. Such an approach has previously been employed for the
Hnrnpa1 and Hnrnpa2b1 genes where upregulation of the Hnrnpa1
gene or the Hnrnpa2 isoform of the Hnrnpa2b1 gene in mouse
hepatocarcinoma cells was shown to cause activation of the RAS-
MAPK-ERK pathway (Shilo et al., 2014). This is potentially important
since a recent study has shown that activation of the RAS-ERK-ETS
pathway is a key determinant of lifespan in Drosophila species (Slack
et al., 2015).
Both in vivo and in vitro studies to moderate the levels or activity of
splicing factors in relation to longevity would not bewithout caveat. Splice
site choice is a complex phenomenon and relies upon the balance of
splicing activators or silencers, rather than the activity of a single splicing
factor per se (Cartegni et al., 2002). This finding, together with obser-
vations that exon and intron splicing enhancers and silencers often cluster
near splice sites, raises the possibility of compensation between splicing
regulatory factors. Selective modulation of a single splicing factor may not
then showdirect effects on longevity, effectswouldmost probably only be
noted after knockdown or overexpression of multiple splicing factors
which would have technical challenges both in vitro and in vivo.
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This study reports the first evidence of a link between expression of
splicing regulator genes and strain lifespan in mice, together with data in
support of potential roles for HNRNPA1 and HNRNPA2B1 in parental
longevity in humans. We hypothesize that an influence of splicing factor
expression on longevity may be mediated by slower immune aging and a
protection from malignancy in the young mice of long-lived strains by
virtue of restricting expression of SR and hnRNP proteins which have
oncogenic potential in young animals. Both of the splicing factor
transcripts demonstrating reduced expression in the old long-lived mice
belonged to the hnRNP class of splicing regulators, indicating that these
mice may have less inhibition of splice site usage and be better able to
maintain splicing, and therefore cellular plasticity into older age. The
changes in splicing factor expression in the spleen are accompanied by
changes in alternatively spliced genes indicative of reduced cell senes-
cence, superior DNA repair and retained cellular proliferative capacity,
and changes in splicing factor expression in muscle are indicative of
lower pro-inflammatory signalling. Our data highlight the importance of
regulation of mRNA processing in determination of lifespan and suggest
that splicing factors may provide novel points of intervention for future
therapies to reduce disease burden in old age. Moreover, since some of
these strains (e.g. C57BL/6J, A/J) are commonly used for the creation and
cross-breeding of genetically modified mice, strain-specific alterations in
alternative splicing could account for unexpected contributions to the
final phenotype arising from the genetic background.
Experimental procedures
Mouse strains used for analysis
Strains were chosen on the basis of differential lifespan (A/J,
NOD.B10Sn-H2b/J, PWD.Phj, 129S1/SvlmJ, C57BL/6J and WSB/EiJ; see
Table 2 for lifespan details) that were measured in a longitudinal study
(Yuan et al., 2009, 2011, 2012) at Jackson Laboratory Nathan Shock
Center of Excellence in the Basic Biology of Aging. Strains with extremely
short lifespans (median lifespan less than 600 days) were excluded on
the basis that a short lifespan may be associated with significant
comorbidities. Characteristics of the mice and the numbers of animals
used in each category are given in Table 2. All mice used in this study
were male. All tissues were obtained from the mice of a cross-sectional
study that was conducted at the same period of time and in the same
mouse room with the longitudinal study. Animal housing conditions
have been fully described previously (Yuan et al., 2009, 2012). Briefly,
mice were fed ad libitum an autoclaved pellet diet with 6% fat and
acidified water (pH 2.8–3.1). Animals were kept on a 12:12-h light/dark
cycle at 50% relative humidity at 21–23 °C, in a restricted access speci-
fic pathogen-free barrier facility. Mice were housed four animals per pen
in individually ventilated polycarbonate cages supplied with HEPA-
filtered air and were tested quarterly for (and were free of) common
viral, bacterial and mycoplasmal species. Mice were inspected daily and
excluded if ill. At 6 or 20/22 months of age, mice were euthanized by
CO2 asphyxiation, followed by blood collection via cardiac puncture and
cervical dislocation. A detailed description of the tissue collection
procedure is given in Data S1. Immediately after death, spleen and
quadriceps muscle tissues were excised and snap-frozen in vapour-phase
liquid nitrogen for storage within 5 min of collection. Tissues were
stored at 80 °C.
Splicing factor candidate genes for analysis
An a priori list of splicing factor candidate genes were chosen on the
basis that they were associated with human aging in populations and in
primary human cell lines that had undergone in vitro senescence in our
previous work (Harries et al., 2011; Holly et al., 2013). The list of genes
included the positive regulatory splicing factors Srsf1, Srsf2, Srsf3, Srsf6,
Srsf18 and Tra2b, the negative regulatory splicing inhibitors Hnrnpa0,
Hnrnpa1, Hnrnpa2b1, Hnrnpd, Hnrnph3, Hnrnpk, Hnrnpm, Hnrnpul2
and the Sf3b1 subunit of the U2 spliceosome snRNP, which we have
previously shown to be associated with age-related altered DNA
methylation (Holly et al., 2014). Assays were obtained in custom
TaqMan low-density array (TLDA) format from Life Technologies (Foster
City, CA, USA). Assay Identifiers are given in Data S1.
Alternatively spliced target genes in spleen
Genes were chosen for assessment of alternative splicing in spleen on
the basis of potential roles in cellular senescence (Cdkn2a), cell cycle
regulation (Trp53, Myc), extracellular matrix (Fn1, Vcan) or DNA damage
response (Atm, Chek2), since these genes may also be important in
Table 2 Characteristics of mouse strains used in this study
Strain Strain Median lifespan (days)* Strain Max Age (days) Longevity class N Young N Old
























*Strain Max Age = the mean of the longest lived 20% within each strain. Data for median and maximum lifespans are given in Yuan et al. (2011) from a longitudinal study
that was performed in conjunction with the cross-sectional study described in the present paper.
The mean lifespan and the maximum lifespan (20% longest lived) are given for each strain used in this study. All mice used in this study were male. Young mice were
6 months old, and old mice were 20–22 months old. Muscle tissue was taken from the quadriceps.
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determination of lifespan. We designed TaqMan quantitative real-time
PCR assays to identify specific isoforms or groups of isoforms (if large
numbers of common regions rendered the design of specific probes
impossible). Assays were obtained in custom TaqMan low-density array
(TLDA) format from Life Technologies. Assay Identifiers are given in Data
S2. A list of transcripts captured by each assay are given in Data S3.
Alternatively spliced target genes in muscle
Genes were selected for analysis of alternative splicing in muscle on the
basis of potential roles in inflammatory processes relating to muscle
remodelling since we have shown in our previous work that these
processes are key determinants of muscle strength in older humans
(Harries et al., 2012; Blackwell et al., 2015). Our gene list included
isoforms of the Il1b, Il6, Nfkb1, Stat1 and Tnf genes. As above, TaqMan
quantitative real-time PCR assays were designed to identify specific
isoforms or groups of isoforms (if large numbers of common regions
rendered the design of specific probes impossible). Assays were obtained
in custom TaqMan low-density array (TLDA) format from Life Technolo-
gies. Assay Identifiers are given in Data S2.
RNA extraction and reverse transcription
Tissue samples were removed from storage and placed in 1 mL TRI
Reagent solution supplemented with the addition of 10 mM MgCl2 to
aid recovery of microRNAs for future analysis (Kim et al., 2012). Samples
were then completely homogenized (15mins for spleen samples, 30mins
for muscle samples) using a bead mill (Retsch Technology GmbH, Haan,
Germany). Phase separation was carried out using chloroform. Total RNA
was precipitated from the aqueous phase by means of an overnight
incubation at 20 °C with isopropanol. RNA pellets were then ethanol-
washed twice and resuspended in RNase-free dH2O. RNA quality and
concentration was assessed by Nanodrop spectrophotometry (Wilming-
ton, DE, USA). Complementary DNA (cDNA) was then reverse-
transcribed from 100 ng total RNA using the Invitrogen VILO cDNA
synthesis kit (Life Technologies) in 20 lL reactions according to
manufacturer’s instructions.
Quantitative real-time PCR and data analysis
Quantitative RT–PCRs were performed on the ABI 7900HT platform (Life
Technologies) on the TaqMan low-density array (TLDA) platform. Cycling
conditions were 50 °C for 2 min, 94.5 °C for 10 min and 50 cycles of
97 °C for 30 s and 57.9 °C for 1 min. The reaction mixes included 50 lL
TaqMan Universal PCR Mastermix II (no AmpErase UNG) (Life
Technologies), 30 lL dH2O and 20 lL cDNA template. 100 lL reaction
solution was dispensed into the TLDA card chamber and centrifuged
twice for 1 min at 216 9 g to ensure distribution of solution to each
well. The expression of transcripts in each sample was measured in
duplicate replicates. The comparative Ct technique was used to calculate
the expression of each test transcript (28). Expression was assessed
relative to the global mean of expression and normalized to the median
level of expression for each individual transcript. Data were log-
transformed to ensure normal distribution of data. Associations of
transcript expression were assessed by linear regression against age, or
lifespan as appropriate. Associations of transcript expression with mouse
age were assessed in all animals and in animals of average-lived or long-
lived strains individually, and associations of transcript expression with
strain lifespan were assessed in all animals and in young and old groups
individually. We also assessed the effect of potential nonlinearity of
response for the splicing factor genes in spleen and muscle by a
secondary analysis using binary logistic regression on data split by the
median lifespan of all the strains. These statistical analyses were carried
out using SPSS v.22 (IBM, North Castle, NY, USA). Interaction between
strain longevity and mouse age was assessed using data categorized into
average-lived or long-lived on the basis of interstrain median lifespan and
was carried out in STATA v.14 (StataCorp, College Station, TX, USA).
Gene expression cluster analysis for heterogeneity of splicing
factor expression with age
The expression of each gene was z-transformed to be on the scale of
standard deviations from the mean, and then the expression values for
each gene were plotted against the corresponding sample to generate a
heat map. Hierarchical clustering methods were used to group similar
expression profiles together. This analysis was done using the ‘HEATMAP.2’
package in R statistical software package v3.1.1 (Vienna, Austria).
Association between splicing factor expression and parental
longevity in the InCHIANTI population
The participants in the InCHIANTI study aged 65+ years were
categorized based on the age at death of their parents, the parental
longevity score (PLS). Participants (total n = 405) were classified as
either ‘two short-lived parents’ (n = 17), ‘one short- and one interme-
diate-lived parent’ (n = 140), ‘two intermediate-lived parents’ (n = 190)
or ‘any long-lived parents’ (n = 58). Short-, intermediate- and long-lived
cut-offs were calculated separately for mothers and fathers based on
the normal distribution of age at death in the cohort, as described in
Dutta et al. (2013a). The cut-offs for mothers were as follows: short-
lived (49–72 years), intermediate-lived (72–95 years) and long-lived
(> 95 years); mothers aged < 49 years at death were classed as
premature and excluded. The cut-offs for fathers were: short-lived
(52–67 years), intermediate-lived (68–89 years) and long-lived
(> 89 years); fathers aged < 52 years at death were classed as
premature and excluded.
To assess the association between the gene expression levels of the
15 splicing factor genes in whole blood as defined in our previous work
(Holly et al., 2013) and parental longevity score, linear regression models
were carried out using R statistical software package v3.1.1 (Vienna,
Austria), with gene expression as the dependent variable. Models were
adjusted for age, sex, waist circumference, highest education level
attained, smoking (pack-years), study site, batches and cell counts
(neutrophils, monocytes, basophils, eosinophils and whole white blood
cell count). Gene expression data were rank-normalized prior to analysis
to remove any skew.
Bioinformatic assessment of potential regulatory effects of
genetic variation within Hnrnpa2b1 and Hnrnpa1 genes
To assess the potential for genetic variation to contribute to splicing
factor expression differences that we observe between strains, we have
carried out a detailed examination of the strain-discordant genetic
differences in the splicing factor genes Hnrnpa2b1 and Hnrnpa1, which
demonstrate links with longevity in both mouse and man. Complete
genome sequence data were available for 4 of the strains we have used
in our analysis (C57BL/6J, 129S1/SvImJ, A/J and WSB/EiJ). SNPs discor-
dant between strains were examined for evidence of effects on gene
regulation by a variety of bioinformatic approaches. Firstly, SNPs located
in the 50 UTR of the Hnrnpa2b1 or Hnrnpa1 genes were assessed for
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position relative to known transcription factor binding sites using
REGRNA2.0 (http://regrna2.mbc.nctu.edu.tw/), an integrated web server
tool that allows screening for potential regulatory elements. Secondly,
intronic SNPs were assessed for their ability to interrupt exon and intron
splicing enhancer and silencer loci using REGRNA2.0 and ESEFINDER (http://
rulai.cshl.edu/cgi-bin/tools/ESE3/esefinder.cgi?process=home), a specific
tool for the identification of splicing regulatory elements. Finally,
sequences in the 30 untranslated region were screened for ability to
disrupt elements with potential to disrupt elements important for mRNA
stability (A-rich elements, C to U RNA editing sites and miRNA binding
sites) using REGRNA2.0.
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